NCT06036342Completed
Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
This study aimed to detect and diagnose atrial fibrillation early by conducting a screening test for atrial fibrillation using a continuous electrocardiography monitoring device for those who have undergone a health screening examination. Early detection through atrial fibrillation screening tests in high-risk patients with stroke is intended to prevent stroke by starting stroke prevention treatment early. It is intended to detect asymptomatic atrial fibrillation patients early through examination and ultimately improve the quality of life.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 3000 (actual)
- First submitted
- 20 Mar 2023
- Start date
- 25 Apr 2022
- Primary completion date
- 10 Dec 2024
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06036342
What you commit to
- Study type: Observational
- Participants enrolled: 3000
- From 25 Apr 2022 to the primary completion date, 10 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects who have patch-type adhesive allergies/atopy dermatitis/ urticaria/skin rash/hives that are difficult to apply patches continuously
- Subjects who have cardiac implantable electronic device (pacemaker, implantable cardioverter-defibrillator, implantable loop recorder, or cardiac resynchronized therapy-pacemaker or defibrillator)
- Subjects requiring immediate ECG analysis or ECG monitoring through hospitalization due to arrhythmia that can be life-threatening
Age
- Subjects aged under 19 years and other vulnerable research subjects
Other
- Subjects diagnosed with atrial fibrillation in the past
- Subjects who have a structural abnormality in the thorax and is difficult to attach the device.
- Subjects who are deemed inappropriate to participate in the research as judged by the researcher for other reasons.
Who the study is looking for
- Subjects aged 65 years or older who have at least one stroke risk factor\*
- Subjects aged 19 years to \<65 years who have two or more stroke risk factors.
- Subjects aged 75 years or older
- Stroke risk factors: heart failure, hypertension, diabetes, vascular disease, women, stroke/systemic embolism/transient ischemic attack (although stroke/systemic embolism/transient ischemic attack among stroke risk factors is considered to have two risk factors)
- Heart failure: a history of heart failure diagnosis or a history of current heart failure treatment.
- Hypertension, Diabetes: Diagnostic History
- Vascular diseases: Significant coronal atherosclerosis (when 70% or more of the computed tomography or coronary angiography is present or coronary intervention is performed), 50% or more of the carotid artery disease, peripheral vascular disease, history of myocardial infarction, and aortic plaques
Age in the registry: 19 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.